These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11151519)

  • 21. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
    Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
    NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
    [No Abstract]   [Full Text] [Related]  

  • 22. The cost of residential addiction treatment in public housing.
    Alexandre PK; Roebuck MC; French MT; Barry M
    J Subst Abuse Treat; 2003 Jun; 24(4):285-90. PubMed ID: 12867201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Service-level costing of drug abuse treatment.
    Anderson DW; Bowland BJ; Cartwright WS; Bassin G
    J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment program operations and costs.
    Broome KM; Knight DK; Joe GW; Flynn PM
    J Subst Abuse Treat; 2012 Mar; 42(2):125-33. PubMed ID: 22154033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A discrete choice model of drug abuse treatment location.
    Goodman AC; Nishiura E; Hankin JR
    Health Serv Res; 1998 Apr; 33(1):125-45. PubMed ID: 9566181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and costs associated with mutual-help community-based recovery homes: The Oxford House model.
    Lo Sasso AT; Byro E; Jason LA; Ferrari JR; Olson B
    Eval Program Plann; 2012 Feb; 35(1):47-53. PubMed ID: 22054524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Socioeconomic analysis of addictions treatment.
    Langenbucher JW
    Public Health Rep; 1996; 111(2):135-7. PubMed ID: 8606910
    [No Abstract]   [Full Text] [Related]  

  • 29. The economic costs of quarterly monitoring and recovery management checkups for adults with chronic substance use disorders.
    Dennis ML; French MT; McCollister KE; Scott CK
    J Subst Abuse Treat; 2011 Sep; 41(2):201-7. PubMed ID: 21466944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs and benefits of combining probation and substance abuse treatment.
    Alemi F; Taxman F; Baghi H; Vang J; Thanner M; Doyon V
    J Ment Health Policy Econ; 2006 Jun; 9(2):57-70. PubMed ID: 17007484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?
    Dismuke CE; French MT; Salomé HJ; Foss MA; Scott CK; Dennis ML
    J Subst Abuse Treat; 2004 Oct; 27(3):253-63. PubMed ID: 15501378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
    Healey A; Knapp M; Marsden J; Gossop M; Stewart D
    J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Godfrey C; Stewart D; Gossop M
    Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social costs of robbery and the cost-effectiveness of substance abuse treatment.
    Basu A; Paltiel AD; Pollack HA
    Health Econ; 2008 Aug; 17(8):927-46. PubMed ID: 17992708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug addict rehabilitation: a burden on society?
    Berg JE; Andersen S
    Int J Rehabil Res; 1992; 15(4):301-9. PubMed ID: 1336768
    [No Abstract]   [Full Text] [Related]  

  • 37. The effectiveness of drug treatment.
    Gerstein DR
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():253-82. PubMed ID: 1311121
    [No Abstract]   [Full Text] [Related]  

  • 38. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment.
    Carlson MJ; Gabriel RM
    Psychiatr Serv; 2001 Sep; 52(9):1230-6. PubMed ID: 11533398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving cost-effectiveness in a substance abuse treatment program.
    Francis E; Hughes P; Schinka J
    Psychiatr Serv; 1999 May; 50(5):633-5. PubMed ID: 10332897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.